Media coverage about Check Cap (NASDAQ:CHEK) has been trending somewhat negative recently, according to Accern Sentiment. The research group identifies negative and positive news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Check Cap earned a daily sentiment score of -0.06 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 46.8064426436494 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Here are some of the media headlines that may have effected Accern’s rankings:
- Brokerages Set $4.58 Target Price for Check Cap Ltd (CHEK) (americanbankingnews.com)
- USCIS sends warning to foreign workers over H1B visas; check what it is about (zeebiz.com)
- Europe Approves Israeli-Developed High-Tech Capsule for Colorectal Cancer Screening (thetower.org)
- Suspect wanted in connection with check fraud in Santee (kusi.com)
A number of research analysts have weighed in on CHEK shares. Zacks Investment Research raised Check Cap from a “hold” rating to a “buy” rating and set a $1.00 target price on the stock in a report on Monday, January 15th. HC Wainwright began coverage on Check Cap in a research report on Tuesday, March 13th. They issued a “buy” rating and a $6.00 price target for the company.
About Check Cap
Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.
Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.